Welcome to our dedicated page for Nature's Sunshine Products news (Ticker: NATR), a resource for investors and traders seeking the latest updates and insights on Nature's Sunshine Products stock.
Nature's Sunshine Products Inc. (NASDAQ: NATR) is a leading natural health and wellness company that manufactures and markets an extensive range of high-quality nutritional and personal care products. Founded in 1972, the company has established itself as a pioneer in the health and wellness industry, offering products such as tablets, encapsulated herbal products, natural vitamins, food supplements, skin care items, and other complementary products.
The company operates on a direct-selling model and has a significant presence in multiple international markets, including but not limited to the United States, South Korea, Mexico, Venezuela, Japan, Brazil, Canada, Central America, Colombia, Ecuador, Peru, the United Kingdom, Israel, and Chile. Additionally, it exports its products to countries such as Argentina, Australia, Malaysia, New Zealand, Norway, and the Russian Federation.
Nature's Sunshine focuses on various health categories, including weight management, general health, cardiovascular health, digestive health, immune support, and personal care. The company's operations are divided into four main segments: Asia, Europe, North America, and Latin America, with Asia being the key revenue-generating market.
Recent achievements highlight the company's robust financial performance. In the latest fiscal reports, Nature's Sunshine recorded net sales up by 12% to $116.5 million, with a 14% increase in constant currency. The third quarter of 2023 saw a GAAP net income rise to $3.1 million and a 50% increase in Adjusted EBITDA to $10.3 million. The company's CEO, Terrence Moorehead, emphasized strong growth in both the Asia/Pacific and North American markets, which contributed to a 12% and 11% increase in local currency sales, respectively.
Nature’s Sunshine's gross margin improved by 150 basis points to 73.1% in Q3 2023 compared to the previous year. These improvements were attributed to market mix enhancements, price increases, and margin improvement initiatives. Selling, general, and administrative expenses (SG&A) rose to $41.3 million due to increased service fees in China, compensation, and investments in digital growth and strategic initiatives.
The company also announced a series of conference calls to discuss its quarterly and annual financial results, providing transparency and updates to shareholders and potential investors. Nature’s Sunshine’s commitment to high-quality, safe, and effective products is evident through its state-of-the-art manufacturing facilities, ensuring products meet the highest standards.
The company's outlook for the future remains positive, with expectations for continued growth in net sales and adjusted EBITDA, driven by strategic initiatives and digital investments designed to enhance market presence and customer engagement.
Nature’s Sunshine Products reported third-quarter 2022 financial results, with net sales of $104.5 million, down from $114.7 million a year ago. GAAP net income was $0.2 million, or $0.00 per share, compared to $5.5 million, or $0.24 per diluted share last year. Adjusted EBITDA fell to $6.8 million from $12.9 million. The company faced challenges including inflation and foreign exchange impacts, which decreased gross margins by 300 basis points. Management aims to achieve $10-$12 million in cost savings over the next 18 months.
Nature's Sunshine Products (NASDAQ: NATR) announced a conference call scheduled for November 3, 2022, at 5:00 p.m. Eastern Time to discuss its third-quarter financial results, ending September 30, 2022. The call will feature CEO Terrence Moorehead and Interim CFO Jon Lanoy, followed by a Q&A session. Participants can join via a toll-free number or watch the live broadcast online. A replay will be available from 8:00 p.m. Eastern Time on the same day until November 17, 2022. Nature's Sunshine is renowned for its high-quality herbal and nutritional products, with a presence in over 40 countries.
Nature's Sunshine Products (Nasdaq: NATR) announced that its CFO, Joseph Baty, will retire on September 30, 2022. Jonathan Lanoy, the Corporate Controller and Vice President of Finance, has been appointed as Interim CFO until a permanent successor is found. CEO Terrence Moorehead acknowledged Baty's contributions to the company, highlighting improvements in financial operations. Nature's Sunshine, which operates in over 40 countries, manufactures high-quality natural health products in its own facilities, ensuring safety and efficacy.
Nature’s Sunshine Products (Nasdaq: NATR) reported second quarter 2022 results, showing net sales of $104.2 million, down from $109.0 million year-over-year. GAAP net income dropped significantly to $1.0 million, or $0.03 per diluted share, compared to $6.8 million or $0.32 per diluted share in the prior year. Adjusted EBITDA also decreased to $9.0 million from $13.4 million. Despite challenges like inflation and supply chain issues, Asia experienced growth. The company continues to invest in growth strategies and reported a strong balance sheet.
Nature’s Sunshine Products, Inc. (NASDAQ: NATR) will host a conference call on August 9, 2022, at 5:00 p.m. Eastern time to discuss its financial results for the second quarter ended June 30, 2022. CEO Terrence Moorehead and CFO Joseph Baty will lead the call, which will include a Q&A session. Participants can join using the provided toll-free and international dial-in numbers. The call will also be available for replay until August 23, 2023. Nature’s Sunshine is recognized for its premium-quality herbal and nutritional products, distributed in over 40 countries.
Nature's Sunshine Products (Nasdaq: NATR) has converted its US manufacturing facility to 100% solar energy, achieving this milestone one year ahead of its ESG target. This switch decreases greenhouse gas emissions by 42%, supporting its broader goals of reducing emissions by 50% by 2025 and achieving zero waste to landfill at US distribution centers. CEO Terrence Moorehead emphasized the company's commitment to sustainability, while VP Trent McCausland expressed pride in this achievement and the ongoing efforts to meet further sustainability goals.
Nature’s Sunshine reported a net sales increase of 8% to $110.5 million for Q1 2022, a record for the company, despite challenges including COVID-19 and supply chain issues. However, the company faced a GAAP net loss of $(2.7 million) compared to a profit of $4.2 million in Q1 2021. Adjusted EBITDA fell to $8.2 million from $11.6 million.
Increased SG&A expenses were noted at $40.6 million. Inventory impairment charges totaled $4.2 million. Cash used in operating activities was $(7.9 million).
Nature's Sunshine Products (NASDAQ: NATR) has appointed Martin Gonzalez as the new Executive Vice President of Global Supply Chain, effective May 16, 2022. With over 30 years of experience at notable companies like Unilever and Molson Coors, Gonzalez is expected to enhance operational excellence and drive transformation within the company's supply chain. His leadership aims to support sustainable growth and expand Nature's Sunshine's global footprint. Gonzalez holds a Global MBA and has a solid track record in supply chain improvements.
Nature’s Sunshine Products (NASDAQ: NATR) will host a conference call on May 5, 2022, at 5:00 p.m. Eastern time to discuss its first-quarter financial results for 2022. CEO Terrence Moorehead and CFO Joseph Baty will present the results, followed by a Q&A session. Investors can join the call using the toll-free number 1-800-768-5121 or the international number 1-312-429-0440. A replay of the call will be available until May 19, 2022. Nature's Sunshine is a leading natural health and wellness company offering herbal and nutritional products globally.
FAQ
What is the current stock price of Nature's Sunshine Products (NATR)?
What is the market cap of Nature's Sunshine Products (NATR)?
What does Nature's Sunshine Products Inc. do?
What are the main health categories that Nature's Sunshine focuses on?
In which regions does Nature's Sunshine operate?
How is Nature's Sunshine’s financial performance?
What are the key revenue-generating markets for Nature's Sunshine?
What recent achievements has Nature's Sunshine made?
How does Nature's Sunshine ensure the quality of its products?
What strategic initiatives is Nature's Sunshine focusing on?
What is Nature's Sunshine's outlook for the future?
How can I get more information about Nature’s Sunshine?
